Sabina A Murphy Selected Research

Thrombolytic Therapy

9/2010	Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
1/2009	Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.
4/2008	Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy.
2/2008	Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
1/2008	Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
6/2007	Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
6/2007	Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
11/2006	Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy.
9/2006	Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy.
4/2006	Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sabina A Murphy Research Topics

Disease

187	Myocardial Infarction 03/2022 - 01/2002
112	Acute Coronary Syndrome 11/2020 - 01/2002
74	Hemorrhage 09/2022 - 12/2002
73	Stroke (Strokes) 09/2022 - 08/2004
64	ST Elevation Myocardial Infarction 01/2020 - 11/2002
37	Heart Failure 07/2022 - 06/2002
35	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
31	Thrombosis (Thrombus) 01/2020 - 07/2002
30	Atrial Fibrillation 09/2022 - 11/2013
30	Unstable Angina 03/2022 - 07/2002
30	Ischemia 10/2018 - 01/2002
22	Ischemic Stroke 01/2022 - 04/2012
21	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 11/2002
21	Atherosclerosis 10/2021 - 02/2003
20	Type 2 Diabetes Mellitus (MODY) 07/2022 - 11/2018
19	Infarction (Infarctions) 01/2016 - 01/2002
18	Infections 01/2020 - 03/2006
15	Peripheral Arterial Disease 09/2022 - 08/2004
14	Coronary Disease (Coronary Heart Disease) 12/2021 - 02/2003
13	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 12/2005
13	Non-ST Elevated Myocardial Infarction 09/2009 - 01/2002
11	Hypertension (High Blood Pressure) 01/2021 - 02/2003
11	Diabetes Mellitus 01/2020 - 10/2002
8	Embolism (Embolus) 09/2022 - 11/2013
8	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016 - 07/2002
8	Inflammation (Inflammations) 01/2016 - 02/2003
8	Pathologic Constriction (Stenosis) 04/2010 - 12/2002
7	Body Weight (Weight, Body) 01/2022 - 05/2002
7	Hemorrhagic Stroke 01/2021 - 08/2014
6	Transient Ischemic Attack 07/2016 - 10/2011
5	Neoplasms (Cancer) 01/2022 - 01/2017
4	Vascular Diseases (Vascular Disease) 01/2018 - 02/2007
4	Chest Pain (Chest Pains) 04/2014 - 07/2003

Drug/Important Bio-Agent (IBA)

39	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2005
38	Clopidogrel (Plavix)FDA Link 01/2020 - 08/2004
26	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 11/2013
26	edoxabanIBA 09/2022 - 11/2013
26	Tirofiban (Aggrastat)FDA Link 09/2008 - 07/2002
24	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 05/2002
21	Prasugrel Hydrochloride FDA Link 01/2020 - 06/2005
21	Heparin (Liquaemin)FDA LinkGeneric 09/2010 - 05/2002
20	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2002
19	dapagliflozinIBA 01/2022 - 01/2019
19	Atorvastatin (Lipitor)FDA Link 09/2015 - 07/2005
18	C-Reactive ProteinIBA 01/2020 - 04/2002
17	evolocumabIBA 12/2021 - 01/2017
17	vorapaxarIBA 01/2020 - 04/2012
17	Pravastatin (Pravachol)FDA LinkGeneric 09/2015 - 12/2005
16	Troponin IIBA 01/2017 - 04/2002
16	Glycoproteins (Glycoprotein)IBA 07/2016 - 11/2002
16	Enoxaparin (Lovenox)FDA LinkGeneric 09/2010 - 05/2002
15	LDL CholesterolIBA 10/2021 - 12/2005
15	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 05/2002
15	N(2)-(3-trifluoromethylphenyl)guanineIBA 02/2008 - 01/2002
14	AnticoagulantsIBA 01/2019 - 04/2005
14	Neurofibromin 2 (Merlin)IBA 10/2015 - 04/2007
13	omega-Chloroacetophenone (Mace)IBA 03/2022 - 06/2007
13	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 04/2002
13	Ranolazine FDA Link 08/2015 - 04/2007
12	Simvastatin (Zocor)FDA LinkGeneric 12/2017 - 12/2005
11	CreatinineIBA 01/2021 - 11/2003
11	Ezetimibe (Zetia)FDA Link 01/2020 - 09/2015
11	TroponinIBA 01/2020 - 09/2003
11	LipidsIBA 07/2012 - 03/2005
10	oxidized low density lipoproteinIBA 10/2021 - 12/2005
10	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2006
10	Pharmaceutical PreparationsIBA 01/2020 - 06/2003
10	Eptifibatide (Integrilin)FDA Link 07/2007 - 05/2004
7	Thrombin Receptors (Thrombin Receptor)IBA 01/2017 - 12/2014
7	CalciumIBA 06/2009 - 02/2005
6	SodiumIBA 01/2021 - 10/2007
6	Sodium-Glucose Transport ProteinsIBA 01/2021 - 01/2019
6	thienopyridineIBA 11/2015 - 11/2007
6	AntithrombinsIBA 09/2010 - 08/2004
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2009 - 10/2002
6	orbofibanIBA 05/2006 - 02/2003
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2019
5	Proprotein Convertase 9IBA 12/2021 - 01/2018
5	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 04/2009
5	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 12/2018 - 02/2016
5	RivaroxabanIBA 10/2018 - 01/2012
5	MB Form Creatine KinaseIBA 10/2015 - 01/2002
5	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 09/2006 - 04/2002
5	Tenecteplase FDA Link 08/2004 - 04/2004
4	PAR-1 ReceptorIBA 04/2019 - 10/2012
4	TicagrelorIBA 01/2018 - 05/2015
4	Factor Xa InhibitorsIBA 01/2017 - 08/2014
4	Vitamin K FDA Link 01/2016 - 08/2014
4	Thrombin FDA Link 11/2015 - 04/2005

Therapy/Procedure

119	Therapeutics 01/2022 - 01/2002
48	Percutaneous Coronary Intervention 12/2021 - 04/2002
23	Thrombolytic Therapy 09/2010 - 10/2002
20	Stents 12/2021 - 01/2002
15	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2021 - 07/2002
14	Secondary Prevention 01/2021 - 03/2005
14	Patient Readmission 07/2012 - 09/2002
6	Conservative Treatment 07/2008 - 07/2002
4	Surgical Amputation (Amputations) 01/2022 - 01/2018
4	Drug-Eluting Stents 12/2021 - 06/2003
4	Drug Tapering 07/2016 - 05/2007